
|Articles|November 26, 2007
Alcon makes final push for WaveLight
Alcon has received all the required regulatory clearances relating to its tender offer for WaveLight AG.
Advertisement
Alcon has received all the required regulatory clearances relating to its tender offer for WaveLight AG.
Upon settlement of all tendered shares, Alcon will own 77.4% of the outstanding WaveLight shares and shareholders who tendered their shares under the offer will automatically receive payment.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Q&A: What the FDA’s class-wide NAION warning on GLP-1s means for eye care
2
Johnson & Johnson to acquire Ollin Biosciences in deal worth up to $3.3 billion
3
Dazodalibep data put Sjögren screening in focus for ophthalmologists
4
The interplay between cardiac disease and the eye
5

















